Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis

Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis

Eltrombopag is an orally administered, non-peptide, thrombopoietin receptor agonist which initiates thrombopoietin signaling and stimulates the production of normally functioning platelet. We aimed to do a systematic review and meta-analysis of currently available published data to verify whether el...

Full description

Bibliographic Details
Main Authors: Hafiz Abdul Waqas Ahmed MD, Ahmed Taher Masoud MD, Jia Han MD, PhD, Ahmed Adel Sofy MD, Ahmed Saeed Ahmed MD, Ahmed Taha Abdesattart MD, Emmanuel Kwateng Drokow MD, PhD, Kai Sun MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2021-04-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296211005555

Internet

https://doi.org/10.1177/10760296211005555

Similar Items